Iluria Ltd. of Israel partners with Ajuba to bring innovative Attention Deficit Hyperactivity Disorder (ADHD) solution for India

Press Note | March 23rd, 2023

Iluria Ltd of Israel partners with Ajuba to bring an innovative Attention Deficit Hyperactivity Disorder (ADHD) precision medicine solution for India. Attention Deficit Hyperactivity Disorder or ADHD is a cognitive disorder that afflicts approximately 2-7% of children globally. ADHD prevalence in India, however, is much higher than the global average. As the disorder can affect a person’s everyday functioning even until adulthood, children suffering from ADHD in India stand the risk of long-term negative outcomes such as lower educational and employment attainment. In terms of social impact, a child with ADHD can cause a lot of anxiety to the people around him, putting strains on parent/sibling-child relationships. In India, a study entitled Prevalence of Attention Deficit Hyperactivity Disorder in Primary School Children that was conducted in Coimbatore found ADHD prevalence in children to be higher than the global estimate, at 11.32%. The highest prevalence is found in ages 9 (at 26.4%) and 10 (at 25%).

Mr. Hagay Levy, CEO and Co-Founder of Iluria Ltd said, “We are looking forward to our partnership with Ajuba to bring this innovative solution for India. Iluria is a validated software that provides in-depth continuous and passive monitoring using any commercial smart wearable. By detecting any ADHD-related pattern, Iluria sheds light on the treatment’s physiological impact, helps parents and doctors manage children’s life with ADHD.”

Mr. Baljit Singh, CEO Ajuba & Chairman, Roar 4 Change said, “ADHD is growing challenge for India. We look forward partnering with Iluria on the innovative Healthcare solution for India. We will be piloting this with clinics and hospitals in the coming months. We look forward to bringing this innovative solution to the doctors and parents dealing with ADHD children and enabling to cope and make it better for their journey of life.”

Are you a doctor/parent and would like to partner with Ajuba, please click below to register?

Click here to register.

About Ajuba:


Ajuba, a boutique consulting company that specializes in developing innovative journey by providing strategy, business development, investments, and sales & marketing services. With its offices in Dallas, Texas, USA and Belapur Navi Mumbai, India the company has been supporting companies in India, Israel and North America (IIN Regions). The services ranges from seeking capital for the start-ups to technology partnership for corporates. The company opens valuable doors, using its extensive network of contacts in India, Israel and USA & Canada to establish channel partnership and joint ventures. We reduce the time to market for products and services with our strategy, business development and investment services.

About Iluria:


Iluria, a digital health start-up that is aiming to revolutionize mental health subjective medication monitoring processes. Iluria’s clinically validated software retrieves physiological markers from commercial level wearables, and by using artificial intelligence provides objective monitoring tools, including personalized medication effectiveness patterns. The software’s proprietary machine learning engine includes several layers of algorithms which analyze the changes in the physiological markers. By this our solution can identify the time units with the medication physiological impact and then apply in-depth analysis which captures the personal treatment patterns.